Comment by AuthAuth
8 hours ago
It shouldnt be limited to companies within the country. Any foreign company can be a market disruptor here. Assuming the drug approval admin isnt working alongside the 'cartel'.
8 hours ago
It shouldnt be limited to companies within the country. Any foreign company can be a market disruptor here. Assuming the drug approval admin isnt working alongside the 'cartel'.
And only in the very particular scenario of a national-only cartel which has not successfully roped in other international pharma companies.
And then there's medical tourism, for the people who prefer to shop at one of the other 'cartels'